Feb 21, 2018 13:01 pm UTC| Business
SAN JOSE, Calif., Feb. 21, 2018 -- Malware sophistication is increasing as adversaries begin to weaponize cloud services and evade detection through encryption, used as a tool to conceal command-and-control activity. To...
Sphere 3D Announces Definitive Agreement to Sell Data Protection and Archive Business
Feb 21, 2018 13:01 pm UTC| Business
SAN JOSE, Calif., Feb. 21, 2018 -- Sphere 3D Corp. (NASDAQ:ANY) (“Sphere 3D”), a containerization, virtualization, and data management solutions provider, today announced that it has entered into a definitive agreement...
Bravatek provides update on its Strategic Acquisition of HelpComm, Inc.
Feb 21, 2018 13:01 pm UTC| Business
AUSTIN, Texas, Feb. 21, 2018 -- via OTC PR WIRE--Bravatek Solutions, Inc. (OTCPink:BVTK) ("Bravatek," or the "Company") anticipates acceleration of revenues through its acquisition of HelpComm, Inc. ("HelpComm") as our...
FTE Awarded $27.5 Million in Contracts by Two Multi-National Fortune 500 Companies
Feb 21, 2018 13:01 pm UTC| Business
NAPLES, Fla., Feb. 21, 2018 -- FTE Networks, Inc. (NYSE American:FTNW) ("FTE" or the "Company"), a leading provider of innovative technology-oriented solutions for smart platforms, network infrastructure and intelligent...
Feb 21, 2018 13:01 pm UTC| Business
JACKSONVILLE, Feb. 21, 2018 -- randrr, the career insights platform, released the results of a new survey that found American students in elementary, middle and high school who are exposed to a limited number of career...
Monster Beverage to Report 2017 Fourth Quarter and Full Year Financial Results on February 28, 2018
Feb 21, 2018 13:01 pm UTC| Business
--Company to Conduct Conference Call at 2:00 p.m. Pacific Time-- CORONA, Calif., Feb. 21, 2018 -- Monster Beverage Corporation (NASDAQ:MNST) announced today that results for its fourth quarter and year-ended December...
Feb 21, 2018 13:01 pm UTC| Business
--Ended 2017 with a healthy cash position of $380M -- --Recently announced FDA approval and launch of Glatopa® 40 mg-- CAMBRIDGE, Mass., Feb. 21, 2018 -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its...